FOLH1 and renal cell adenocarcinoma: Conversely from what observed in ccRCC, PSMA-targeted PET/CT showed overall poor performance in other RCC subtypes when compared to conventional imaging [52]; moreover, weaker PSMA staining was found in RCC subtypes other than ccRCC [61].